NO20014301D0 - Sammensetninger med kontrollert frigivelse av betahistin - Google Patents

Sammensetninger med kontrollert frigivelse av betahistin

Info

Publication number
NO20014301D0
NO20014301D0 NO20014301A NO20014301A NO20014301D0 NO 20014301 D0 NO20014301 D0 NO 20014301D0 NO 20014301 A NO20014301 A NO 20014301A NO 20014301 A NO20014301 A NO 20014301A NO 20014301 D0 NO20014301 D0 NO 20014301D0
Authority
NO
Norway
Prior art keywords
compositions
controlled release
betahistine
release betahistine
controlled
Prior art date
Application number
NO20014301A
Other languages
English (en)
Other versions
NO20014301L (no
NO319135B1 (no
Inventor
Flavio Fabiani
Enrico Frimonti
Mauro Valenti
Original Assignee
Farmaceutici Formenti Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Formenti Spa filed Critical Farmaceutici Formenti Spa
Publication of NO20014301L publication Critical patent/NO20014301L/no
Publication of NO20014301D0 publication Critical patent/NO20014301D0/no
Publication of NO319135B1 publication Critical patent/NO319135B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO20014301A 1999-03-05 2001-09-04 Sammensetninger med kontrollert frigivelse av betahistin NO319135B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000454A IT1309591B1 (it) 1999-03-05 1999-03-05 Composizioni a rilascio controllato di betaistina.
PCT/EP2000/001642 WO2000053162A1 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Publications (3)

Publication Number Publication Date
NO20014301L NO20014301L (no) 2001-09-04
NO20014301D0 true NO20014301D0 (no) 2001-09-04
NO319135B1 NO319135B1 (no) 2005-06-20

Family

ID=11382165

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014301A NO319135B1 (no) 1999-03-05 2001-09-04 Sammensetninger med kontrollert frigivelse av betahistin

Country Status (37)

Country Link
EP (1) EP1158963B1 (no)
JP (1) JP2002538197A (no)
KR (1) KR20010102498A (no)
CN (1) CN1165295C (no)
AR (1) AR029154A1 (no)
AT (1) ATE231392T1 (no)
AU (1) AU762532B2 (no)
BG (1) BG105807A (no)
BR (1) BR0008739A (no)
CA (1) CA2364226A1 (no)
CO (1) CO5170438A1 (no)
CZ (1) CZ299510B6 (no)
DE (1) DE60001266T2 (no)
DK (1) DK1158963T3 (no)
EE (1) EE200100453A (no)
ES (1) ES2189739T3 (no)
GE (1) GEP20033078B (no)
HK (1) HK1042246B (no)
HR (1) HRP20010650A2 (no)
HU (1) HUP0200243A2 (no)
ID (1) ID30127A (no)
IL (1) IL145263A0 (no)
IT (1) IT1309591B1 (no)
MX (1) MXPA01008893A (no)
NO (1) NO319135B1 (no)
NZ (1) NZ513949A (no)
PE (1) PE20001547A1 (no)
PL (1) PL196290B1 (no)
PT (1) PT1158963E (no)
RU (1) RU2248791C2 (no)
SI (1) SI1158963T1 (no)
SK (1) SK284584B6 (no)
TR (1) TR200102566T2 (no)
UA (1) UA65652C2 (no)
WO (1) WO2000053162A1 (no)
YU (1) YU64001A (no)
ZA (1) ZA200107318B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064807A1 (en) * 2003-01-23 2004-08-05 Amorepacific Corporation Sustained-release preparations and method for producing the same
DE60320965D1 (de) 2003-07-04 2008-06-26 Formenti Farmaceutici Spa Betahistinezubereitungen mit kontrollierter Freisetzung
US7728015B2 (en) 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
JP2007533733A (ja) 2004-04-22 2007-11-22 モル リサーチ アプリケーションズ リミテッド 食物摂取管理の方法
EP1771159A4 (en) * 2004-07-22 2009-04-29 Amorepacific Corp SLOW RELEASE PREPARATIONS CONTAINING TOPIRAMATE AND PROCESS FOR PRODUCING THE SAME
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
ES2419204T3 (es) 2008-05-27 2013-08-19 The University Of Melbourne Métodos para tratar a mamíferos con disfunciones de la trompa de Eustaquio
EP2314296A1 (en) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally Disintegrating Tablets of Betahistine
EP2491930A1 (en) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
DE102012105528A1 (de) 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
EP3431078B1 (en) * 2017-07-20 2021-01-20 Intas Pharmaceuticals Limited Non-pulsatile prolonged-release betahistine oral solid compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
AU744156B2 (en) * 1996-10-28 2002-02-14 General Mills Inc. Embedding and encapsulation of controlled release particles

Also Published As

Publication number Publication date
SK284584B6 (sk) 2005-07-01
KR20010102498A (ko) 2001-11-15
EP1158963A1 (en) 2001-12-05
EE200100453A (et) 2002-12-16
PL350232A1 (en) 2002-11-18
HK1042246A1 (en) 2002-08-09
NO20014301L (no) 2001-09-04
ES2189739T3 (es) 2003-07-16
RU2248791C2 (ru) 2005-03-27
JP2002538197A (ja) 2002-11-12
DK1158963T3 (da) 2003-04-28
CO5170438A1 (es) 2002-06-27
IL145263A0 (en) 2002-06-30
AU762532B2 (en) 2003-06-26
CN1342069A (zh) 2002-03-27
ID30127A (id) 2001-11-08
CN1165295C (zh) 2004-09-08
DE60001266D1 (de) 2003-02-27
IT1309591B1 (it) 2002-01-24
YU64001A (sh) 2004-05-12
NO319135B1 (no) 2005-06-20
PL196290B1 (pl) 2007-12-31
TR200102566T2 (tr) 2002-01-21
ATE231392T1 (de) 2003-02-15
MXPA01008893A (es) 2002-10-23
BR0008739A (pt) 2001-12-26
AU3283100A (en) 2000-09-28
CZ299510B6 (cs) 2008-08-20
DE60001266T2 (de) 2003-08-28
EP1158963B1 (en) 2003-01-22
WO2000053162A1 (en) 2000-09-14
ZA200107318B (en) 2002-09-04
BG105807A (bg) 2002-03-29
PE20001547A1 (es) 2001-01-29
AR029154A1 (es) 2003-06-18
HRP20010650A2 (en) 2002-10-31
HUP0200243A2 (en) 2002-06-29
PT1158963E (pt) 2003-06-30
UA65652C2 (uk) 2004-04-15
NZ513949A (en) 2003-10-31
HK1042246B (zh) 2005-06-03
SK12492001A3 (sk) 2001-12-03
ITMI990454A1 (it) 2000-09-05
GEP20033078B (en) 2003-10-27
CZ20013186A3 (cs) 2002-02-13
CA2364226A1 (en) 2000-09-14
SI1158963T1 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
NO20021540L (no) Sammensetninger med kontrollert frigivelse omfattende nimesulfid
DK0922386T3 (da) Sammensætninger med reguleret frigivelse
NO20012857L (no) Galantaminsammensetning med kontrollert frigivelse
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
ATE490327T1 (de) Impfstoffzusammensetzung
AR027907A1 (es) Composicion de liberacion controlada
IS6120A (is) Lyfjablanda
PT1210113E (pt) Composicoes de vacinas de combinacao
AR023440A1 (es) Composiciones antitranspirantes
ID29785A (id) Komposisi-komposisi sampo
DK1142477T3 (da) Sammensætninger med reguleret frigivelse
ATE257691T1 (de) Schweisshemmende zusammensetzungen
DE69925167D1 (de) Hochwitterungsbeständige pulverlackzusammensetzung
DK1218096T3 (da) Mikrokapsler med variabel frisætning
DE69943245D1 (de) Gaserzeugende zusammensetzung
NO20014301L (no) Sammensetninger med kontrollert frigivelse av betahistin
NO20021452L (no) Orale kontrollerte frigivelsesformuleringer
DE60008839D1 (de) Duftstoff-Zusammensetzung
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
ID27329A (id) Komposisi penghambat
DK1212095T3 (da) Fremgangsmåde til fremstilling af en formulering med opretholdt frigivelse
DE60008950D1 (de) Keramikzusammensetzung
DE60029780D1 (de) Biozide zusammensetzungen
FR2792306B1 (fr) Composition derivee de bi26mo10o69
DE60020836D1 (de) Flammhemmende zusammensetzungen